BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1321888)

  • 1. The coordination of copper(II) to 1-hydroxy-4-(glycyl-histidyl-lysine)-anthraquinone; a synthetic model of anthraquinone anti-cancer drugs.
    Pettit LD; Ueda J; Morier-Teissier E; Helbecque N; Bernier JL; Henichart JP; Kozlowski H
    J Inorg Biochem; 1992 Feb; 45(3):203-10. PubMed ID: 1321888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coordination abilities of neurokinin A and its derivative and products of metal-catalyzed oxidation.
    Kowalik-Jankowska T; Jankowska E; Szewczuk Z; Kasprzykowski F
    J Inorg Biochem; 2010 Aug; 104(8):831-42. PubMed ID: 20435351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Copper complexes of glycyl-histidyl-lysine and two of its synthetic analogues: chemical behaviour and biological activity.
    Conato C; Gavioli R; Guerrini R; Kozlowski H; Mlynarz P; Pasti C; Pulidori F; Remelli M
    Biochim Biophys Acta; 2001 May; 1526(2):199-210. PubMed ID: 11325542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coordination of copper(II) ions by the fragments of neuropeptide gamma containing D1, H9, H12 residues and products of copper-catalyzed oxidation.
    Jankowska E; Pietruszka M; Kowalik-Jankowska T
    Dalton Trans; 2012 Feb; 41(6):1683-94. PubMed ID: 22159001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of terminal amino group and histidine at the fourth position in the metal ion binding of oligopeptides revisited: Copper(II) and nickel(II) complexes of glycyl-glycyl-glycyl-histamine and its N-Boc protected derivative.
    Jancsó A; Selmeczi K; Gizzi P; Nagy NV; Gajda T; Henry B
    J Inorg Biochem; 2011 Jan; 105(1):92-101. PubMed ID: 21134607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interaction of antitumor-active anthraquinones with biologically important redox couples: I. Spectrophotometric investigation of the interaction of carminic acid and mitoxantrone with the iron (II, III) and copper (I, II) redox couples.
    Tütem E; Apak R; Sözgen K
    J Inorg Biochem; 1996 Feb; 61(2):79-96. PubMed ID: 8576709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of histidine containing peptides for better understanding of their coordination mode toward copper(II) by CD spectroscopy.
    Jakab NI; Gyurcsik B; Körtvélyesi T; Vosekalna I; Jensen J; Larsen E
    J Inorg Biochem; 2007 Oct; 101(10):1376-85. PubMed ID: 17628687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. X-ray and solution structures of Cu(II) GHK and Cu(II) DAHK complexes: influence on their redox properties.
    Hureau C; Eury H; Guillot R; Bijani C; Sayen S; Solari PL; Guillon E; Faller P; Dorlet P
    Chemistry; 2011 Aug; 17(36):10151-60. PubMed ID: 21780203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complex formation processes of terminally protected peptides containing two or three histidyl residues. Characterization of the mixed metal complexes of peptides.
    Rajković S; Kállay C; Serényi R; Malandrinos G; Hadjiliadis N; Sanna D; Sóvágó I
    Dalton Trans; 2008 Oct; (37):5059-71. PubMed ID: 18802621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ternary Cu(II) Complex with GHK Peptide and
    Bossak-Ahmad K; Wiśniewska MD; Bal W; Drew SC; Frączyk T
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32867146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ternary Cu
    Bossak-Ahmad K; Bal W; Frączyk T; Drew SC
    Inorg Chem; 2021 Nov; 60(22):16927-16931. PubMed ID: 34730942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Copper(II) complexation by pituitary adenylate cyclase activating polypeptide fragments.
    Kowalik-Jankowska T; Jasionowski M; Lankiewicz L
    J Inorg Biochem; 1999 Jul; 76(1):63-70. PubMed ID: 10530007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Copper(II) interaction with prion peptide fragments encompassing histidine residues within and outside the octarepeat domain: speciation, stability constants and binding details.
    Osz K; Nagy Z; Pappalardo G; Di Natale G; Sanna D; Micera G; Rizzarelli E; Sóvágó I
    Chemistry; 2007; 13(25):7129-43. PubMed ID: 17566127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling of copper(II) sites in proteins based on histidyl and glycyl residues.
    Orfei M; Alcaro MC; Marcon G; Chelli M; Ginanneschi M; Kozlowski H; Brasuń J; Messori L
    J Inorg Biochem; 2003 Nov; 97(3):299-307. PubMed ID: 14511892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insertion of beta-alanine in model peptides for copper binding to His96 and His111 of the human prion protein.
    Rivillas-Acevedo L; Maciel-Barón L; García JE; Juaristi E; Quintanar L
    J Inorg Biochem; 2013 Sep; 126():104-10. PubMed ID: 23796442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Similarities and differences of copper and zinc cations binding to biologically relevant peptides studied by vibrational spectroscopies.
    Schirer A; El Khoury Y; Faller P; Hellwig P
    J Biol Inorg Chem; 2017 Jun; 22(4):581-589. PubMed ID: 28321603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Copper(II) coordination properties of the integrin ligand sequence PHSRN and its new β-cyclodextrin conjugates.
    Magrì A; D'Alessandro F; Distefano DA; Campagna T; Pappalardo G; Impellizzeri G; La Mendola D
    J Inorg Biochem; 2012 Aug; 113():15-24. PubMed ID: 22687490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complexation abilities of neuropeptide gamma toward copper(II) ions and products of metal-catalyzed oxidation.
    Pietruszka M; Jankowska E; Kowalik-Jankowska T; Szewczuk Z; Smużyńska M
    Inorg Chem; 2011 Aug; 50(16):7489-99. PubMed ID: 21770367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Copper(II) complex formation with a linear peptide encompassing the putative cell binding site of angiogenin.
    La Mendola D; Magrì A; Vagliasindi LI; Hansson Ö; Bonomo RP; Rizzarelli E
    Dalton Trans; 2010 Nov; 39(44):10678-84. PubMed ID: 20941439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Free radical production and DNA cleavage by copper chelating peptide-anthraquinones.
    Morier-Teissier E; Bernier JL; Lohez M; Catteau JP; Hénichart JP
    Anticancer Drug Des; 1990 Aug; 5(3):291-305. PubMed ID: 2400540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.